SCHEMBL6649736

SCHEMBL6649736

Cc1cc2nc(NC(=O)C(C)(C)C)[nH]c(=O)c2c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
RAB9A P51151 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 2/20 0.41
XBP1 P17861 1/20 0.41
POLB P06746 2/20 0.40
TSHR P16473 1/20 0.40
BLM P54132 1/20 0.39
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651272 0.84 TYMS (0.47) TYMSSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL8924144 0.83 RAB9A (0.40) TYMSSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL8924156 0.82 TYMS (0.46) TYMSSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL6650303 0.79 TYMS (0.58) TYMSSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL6447534 0.79 TYMS (0.56) TYMSSMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL1369022 0.77 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDRAB9AMEN1
SCHEMBL6650779 0.75 TYMS (0.62) TYMSSMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL6652207 0.75 TYMS (0.57) TYMSSMN1; SMN2ALDH1A1HPGD
SCHEMBL29850712 0.75 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1HPGDRAB9AMEN1
SCHEMBL15290198 0.75 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1HPGDRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed